There are common plastic surgery procedures, such as facelifts and breast augmentation that have been performed for decades. To battle aging, people may turn to cosmetics in order to look more youthful. Recently, there has been an increase in superficial procedures that may be extremely unnecessary and dangerous. Here is a look at some new and surprising cosmetic procedures. Continue reading
Many people may welcome growing older because of the wisdom from one’s wealth of experience that comes with aging, but looking older is another matter. All over the world, people are beginning to undergo a number of treatments, therapies and rituals in order to appear younger, healthier and better looking. This practice that has spawned a billion-dollar beauty industry that includes cosmetics and other products that prevent and repair aging skin. Here is a look at the different treatments available to turn back time: Continue reading
Can It Be Bigger and Better?
However, the new drug is likely to find it tough to win over the market mainly because Botox performs so well. To outdo its competitors, the new drug has to work faster, produce long lasting effects, and/or be more affordable than Botox. The good news for J&J customers is that they have brilliant researchers who produce great products. Even with that, loyal Botox consumers might take time to switch to the new product because Allergan, the manufacturer of Botox, has built a strong brand.
Will J&J Add Medical Benefits?
Some of its other medical uses include treating migraines, overactive bladders, and sweaty underarms.
Joining the Competition
Granted, several companies have already introduced anti-wrinkle cosmetics treatments in a bid to wrest market share from Botox including MerzPharma Group’s Xeomin and Valeant Pharmaceuticals International Inc.’s Dysport. However, the aforementioned drugs have only yielded a paltry 15% market combined. J&J expects to grab the number two market spot ahead of Dysport and Xeomin.
Morningstar believes that competition will be quite fierce in emerging markets where Botox has not made serious inroads such as South America and Asia. In addition, the drug is likely to find acceptance among people looking for the next big revelation that can deliver superior cosmetics results particularly in terms of youthful and wrinkle free skin.
Most Hollywood celebrities try their best to look beautiful even when they are out of the spotlight, so imagine the effort that goes into making them red-carpet ready for big events such as the Oscars. On a night when thousands of stars from around the globe converge on a single spot on the planet, every celebrity wants to be at his or her most beautiful and resplendent. Here is a look at how well planned and orchestrated the beauty routines and fitness procedures are months before a special event. Continue reading
On January 9, 2013 the 10-month court injunction on Botox competitor Xeomin expired. Simon Ourian, M.D. of Epione Beverly Hills says that competition is good for the industry. Continue reading
LOS ANGELES, Calif. – Medicis Pharmaceutical Corporation, a leading independent specialty pharmaceutical company based in the U.S., recently invited Dr. Simon Ourian to participate in a meeting of the company’s advisory board. Ourian, medical director of Epione Medical Corporation in Beverly Hills, joins an elite group of the world’s top physicians selected based on their expertise and reputation as leading injectors.
First launched in 1988, Medicis is a leading manufacturer of branded prescription products in a number of therapeutic and aesthetic categories. The company’s products are widely used by physicians and patients and have earned a reputation for their clinical effectiveness, high quality and cosmetic elegance. Medicis’ products include Restylane, Dysport, Perlane, and Esoterica, among others.
As technology and medicine advance, doctors have found even better ways to get rid of wrinkles, laugh lines, and other signs of aging. Some use existing methods, like disease fighting drugs and others use more precise instruments. As a result, first generation treatments are being outstripped by their second generation heirs. Dermal fillers once lasted three to six months; now, they can last two years or more. New minimally invasive procedures mean that we can not only get work done during our lunch break, but we’ll even have time to meet up for a bite right afterward. Intense swelling and painful abrasion are being replaced by (nearly) painless light and lasers.
We no longer have to worry about finding a place to hide while a facelift heals. Today’s skin treatments show full results in days. And in the future, that time could be cut down to hours or even minutes.
In addition, not only are the older treatments being replaced by better, faster ones, but they are often are less expensive. The economy may be improving, according to some, but people are still putting off elective procedures in the interests of saving money. Plastic surgeons and other doctors understand this, and in turn, they have reduced their prices and created effective promotions.
Dysport Moving in On Botox’s Turf
“I don’t think the introduction of Dysport will spark a price war with Botox. But it will give us another tool we can use to better serve our patients, “ says Dr. Simon Ourian, a cosmetic Dermatologist with a thriving practice in Beverly Hills. Both drugs are made from the bacteria Chlostridium botulinum, a known toxin that causes botulism in food, in minuscule amounts. Dysport was recently FDA approved, and will also be used to fight wrinkles.
Lashes Like a Newborn
Allergan Inc, the makers of Botox, have stumbled upon yet another exciting discovery. Their bimatopost ophthmalmic solution, first used to treat glaucoma, was found to stimulate the growth of eyelashes in a big way. Ophthalmologists noted that their patients’ lashes were longer, darker and thicker than before. The formula was changed slightly and went through the FDA process, and the result is Latisse.
Dr. Ourian has only positive reviews of this treatment. “The application process is simple, “ he says, “and each Latisse kit comes with sterile applicators so that when used properly there is no chance for cross-contamination.” There are potential side effects, of course—itchy eyelids and skin discoloration in the eye area—but the patients seem to have no problem with them. And they’re willing to do whatever it takes to grow their lashes. “Allergan really hit the mark with Latisse, “ says Dr. Ourian. “Women spend a billion dollars a year on cosmetics to achieve the appearance of longer, fuller lashes. Latisse can actually grow your lashes.”